Moreover, we employed another JMJD3 inhibitor GSK-J4 and found similar results concerning the synergistic inhibitory effects between TCP and GSK-J4 in HNSCC (Supplementary Fig. 3). The gene discussed is KDM6B; the disease is head and neck squamous cell carcinoma.